Staphylococcus aureus Augments Epithelial Skin Barrier Damage Through T Cell Activation in Cutaneous T Cell Lymphoma
| dc.contributor.author | Gluud, Maria | |
| dc.contributor.author | Pallesen, Emil M. | |
| dc.contributor.author | Zeng, Ziao | |
| dc.contributor.author | Namini, Martin R. J. | |
| dc.contributor.author | Vadivel, Chella Krishna | |
| dc.contributor.author | Gjerdrum | |
| dc.contributor.author | Lise Mette Rahbek | |
| dc.contributor.author | Yan, Lang | |
| dc.contributor.author | Ahmad, Sana | |
| dc.contributor.author | Lindahl, Lise M. | |
| dc.contributor.author | Bzorek, Michael | |
| dc.contributor.author | Kamstrup, Maria R. | |
| dc.contributor.author | Dey, Saptaswa | |
| dc.contributor.author | Ostrowski, Sisse Rye | |
| dc.contributor.author | Sorensen, Erik | |
| dc.contributor.author | Rantakari, Pia | |
| dc.contributor.author | Bonefeld, Charlotte Menne | |
| dc.contributor.author | Geisler, Carsten | |
| dc.contributor.author | Woetmann, Anders | |
| dc.contributor.author | Lahesmaa, Riitta | |
| dc.contributor.author | Iversen, Lars | |
| dc.contributor.author | Wolf, Peter | |
| dc.contributor.author | Litman, Thomas | |
| dc.contributor.author | Buus, Terkild B. | |
| dc.contributor.author | Odum, Niels | |
| dc.contributor.organization | fi=biolääketieteen laitos|en=Institute of Biomedicine| | |
| dc.contributor.organization | fi=Turun biotiedekeskus|en=Turku Bioscience Centre| | |
| dc.contributor.organization | fi=InFLAMES Lippulaiva|en=InFLAMES Flagship| | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.18586209670 | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.77952289591 | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.68445910604 | |
| dc.converis.publication-id | 516087552 | |
| dc.converis.url | https://research.utu.fi/converis/portal/Publication/516087552 | |
| dc.date.accessioned | 2026-04-24T17:43:45Z | |
| dc.description.abstract | <div><h3>Background</h3><p>Skin barrier dysfunction is central to inflammation and susceptibility to infection in atopic dermatitis (AD). Cutaneous T-cell lymphoma (CTCL) shares clinical similarities with AD and is also associated with a high prevalence of <em>Staphylococcus aureus</em> (<em>S. aureus</em>) colonisation. However, the mechanisms driving skin barrier damage in CTCL and the contribution of bacteria remain poorly understood.</p><h3>Methods</h3><p>We investigate how the interplay between <em>S. aureus</em> (and staphylococcal enterotoxins (SEs)) and primary malignant- and non-malignant T cells affects keratinocyte expression of skin barrier proteins; in vitro, in an EL4 murine lymphoma model of bacteria-driven tumour progression, and in CTCL patient lesions colonised with SE-producing <em>S. aureus</em> before and after bacterial eradication by antibiotic treatment.</p><h3>Results</h3><p><em>S. aureus</em> and SEs activate malignant and non-malignant T cells to release barrier-repressing cytokines, including IL-4, IL-13, IL-22, and OSM, and JAK-dependent downregulation of filaggrin and loricrin in keratinocytes. In the EL4 model, bacteria-colonised tumour-bearing mice show significant filaggrin loss in tumour-adjacent epidermis, whereas antibiotic-treated mice maintain near-normal expression. Clinically, antibiotic eradication of SE-producing <em>S. aureus</em> partially restores filaggrin and loricrin expression in three of four patients, paralleling reduced inflammatory signalling.<br></p><h3>Conclusions</h3><p>SE-producing <em>S. aureus</em> promotes skin barrier impairment in CTCL through cytokine-driven, JAK-dependent repression of structural proteins in keratinocytes. These findings identify microbial–immune crosstalk as a contributor to CTCL skin pathology and provide mechanistic rationale for strategies targeting <em>S. aureus</em> colonisation as adjunctive therapy in CTCL.</p></div> | |
| dc.identifier.eissn | 1398-9995 | |
| dc.identifier.jour-issn | 0105-4538 | |
| dc.identifier.uri | https://www.utupub.fi/handle/11111/59066 | |
| dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1111/all.70292 | |
| dc.identifier.urn | URN:NBN:fi-fe2026042333022 | |
| dc.language.iso | en | |
| dc.okm.affiliatedauthor | Rantakari, Pia | |
| dc.okm.affiliatedauthor | Lahesmaa, Riitta | |
| dc.okm.discipline | 3111 Biomedicine | en_GB |
| dc.okm.discipline | 3111 Biolääketieteet | fi_FI |
| dc.okm.internationalcopublication | international co-publication | |
| dc.okm.internationality | International publication | |
| dc.okm.type | A1 ScientificArticle | |
| dc.publisher | Wiley-Blackwell | |
| dc.publisher.country | United Kingdom | en_GB |
| dc.publisher.country | Britannia | fi_FI |
| dc.publisher.country-code | GB | |
| dc.relation.doi | 10.1111/all.70292 | |
| dc.relation.ispartofjournal | Allergy | |
| dc.title | Staphylococcus aureus Augments Epithelial Skin Barrier Damage Through T Cell Activation in Cutaneous T Cell Lymphoma | |
| dc.year.issued | 2026 |
Tiedostot
1 - 1 / 1
Ladataan...
- Name:
- Allergy - 2026 - Gluud - Staphylococcus aureus Augments Epithelial Skin Barrier Damage Through T Cell Activation in.pdf
- Size:
- 5.63 MB
- Format:
- Adobe Portable Document Format